NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.79M | 15.68M | 15.89M | 16.03M | 17.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.79M | 15.68M | 15.89M | 16.03M | 17.08M |
| Cost of Revenue | 13.60M | 12.80M | 12.97M | 12.97M | 13.70M |
| Gross Profit | 3.19M | 2.88M | 2.91M | 3.06M | 3.38M |
| SG&A Expenses | 2.02M | 1.86M | 2.51M | 2.30M | 2.18M |
| Depreciation & Amortization | 421.20K | 395.80K | 403.80K | 404.40K | 414.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.04M | 15.05M | 15.88M | 15.68M | 16.29M |
| Operating Income | 743.40K | 628.40K | 5.00K | 355.00K | 784.20K |
| Income Before Tax | 585.90K | 341.20K | -271.10K | 18.20K | 354.20K |
| Income Tax Expenses | -625.70K | 64.90K | -31.60K | 86.40K | 107.00K |
| Earnings from Continuing Operations | 1.21M | 276.30K | -239.60K | -68.20K | 247.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -61.40K | -48.10K | -53.80K | -42.80K | -60.70K |
| Net Income | 1.15M | 228.20K | -293.40K | -111.10K | 186.50K |
| EBIT | 743.40K | 628.40K | 5.00K | 355.00K | 784.20K |
| EBITDA | 1.16M | 1.02M | 185.40K | 759.40K | 1.20M |
| EPS Basic | 0.02 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.02 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 56.33M | 56.29M | 56.21M | 56.45M | 56.57M |
| Average Diluted Shares Outstanding | 60.27M | 59.29M | 56.21M | 58.26M | 58.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |